Type-2 diabetics is associated with poor impulse control

Type-2 diabetes, an increasingly common complication of obesity, is associated with poor impulse control. Researchers writing in BioMed Central's open access journal BioPsychoSocial Medicine suggest that neurological changes result in this inability to resist temptation, which may in turn exacerbate diabetes.

Hiroaki Kumano, from Waseda University, Japan, worked with a team of researchers to assess response inhibition, a measure of self-control, in 27 patients with type-2 diabetes and 27 healthy controls.  He said, "Patients with type 2 diabetes are required to make strict daily decisions; for example, they should resist the temptation of high-fat, high-calorie food, which is frequently cued by specific people, places and events. Appropriate behavior modification thus depends on the patient's ability to inhibit impulsive thoughts and actions cued by these environmental stimuli".

In order to gauge the patients' ability to resist such impulsive behavior, the researchers used a test in which participants had to quickly press a button in response to the correct signal on a computer screen, while pressing the button in response to the wrong symbol counted against their score. They found that patients with diabetes performed significantly worse at the test, suggesting that they struggled to control the impulse to press the button. Other results showed that the inhibitory failure observed in diabetic patients was mainly explained by cognitive impairment of impulsivity control, rather than by deficits in motor performance, error monitoring and adjustment. According to Kumano, "This suggests the possibility that the neuropsychological deficits in response inhibition may contribute to the behavioral problems leading to chronic lifestyle-related diseases, such as type 2 diabetes".

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Anti-obesity drugs show promise in improving cardiovascular health beyond weight loss